Regulus Therapeutics Inc. (RGLS), a company specializing in microRNA-targeted medicines, announced on Thursday the promotion of Rekha Garg to Chief Medical Officer, effective May 16. Previously, Garg held the position of Senior Vice President, Clinical Development and Regulatory at the company.
FX.co ★ Regulus Promotes Rekha Garg As Chief Medical Officer
Regulus Promotes Rekha Garg As Chief Medical Officer
*Die zur Verfügung gestellte Marktanalyse dient zu den Informationszwecken und sollte als Anforderung zur Eröffnung einer Transaktion nicht ausgelegt werden